Format
Items per page
Sort by

Send to:

Choose Destination

Results: 19

Related Articles by Review for PubMed (Select 23166563)

1.

Duloxetine in affective disorders: a naturalistic study on psychiatric and medical comorbidity, use in association and tolerability across different age groups.

Dell'osso B, Camuri G, Dobrea C, Buoli M, Serati M, Altamura AC.

Clin Pract Epidemiol Ment Health. 2012;8:120-5. doi: 10.2174/1745017901208010120. Epub 2012 Nov 2.

2.

Duloxetine: a review of its use in the treatment of generalized anxiety disorder.

Carter NJ, McCormack PL.

CNS Drugs. 2009;23(6):523-41. doi: 10.2165/00023210-200923060-00006. Review.

PMID:
19480470
3.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
4.

Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature.

Mancini M, Perna G, Rossi A, Petralia A.

Expert Opin Pharmacother. 2010 May;11(7):1167-81. doi: 10.1517/14656561003747441. Review. Erratum in: Expert Opin Pharmacother. 2010 Jun;11(8):1443.

PMID:
20402555
5.

Duloxetine in the treatment of major psychiatric and neuropathic disorders.

Müller N, Schennach R, Riedel M, Möller HJ.

Expert Rev Neurother. 2008 Apr;8(4):527-36. doi: 10.1586/14737175.8.4.527. Review.

PMID:
18416656
6.

[Efficacy and tolerability of escitalopram in anxiety disorders: a review].

Pelissolo A.

Encephale. 2008 Sep;34(4):400-8. doi: 10.1016/j.encep.2008.04.004. Epub 2008 Aug 15. Review. French.

PMID:
18922243
7.

Paroxetine: an update of its use in psychiatric disorders in adults.

Wagstaff AJ, Cheer SM, Matheson AJ, Ormrod D, Goa KL.

Drugs. 2002;62(4):655-703. Review. Erratum in: Drugs 2002;62(10):1461.

PMID:
11893234
8.

Spotlight on paroxetine in psychiatric disorders in adults.

Wagstaff AJ, Cheer SM, Matheson AJ, Ormrod D, Goa KL.

CNS Drugs. 2002;16(6):425-34. Review.

PMID:
12027788
9.

Duloxetine hydrochloride: a new dual-acting medication for the treatment of major depressive disorder.

Hunziker ME, Suehs BT, Bettinger TL, Crismon ML.

Clin Ther. 2005 Aug;27(8):1126-43. Review.

PMID:
16199241
10.

Psychiatric and medical comorbidities of bipolar disorder.

Krishnan KR.

Psychosom Med. 2005 Jan-Feb;67(1):1-8. Review.

PMID:
15673617
11.
12.

Overview and clinical presentation of generalized anxiety disorder.

Rickels K, Rynn M.

Psychiatr Clin North Am. 2001 Mar;24(1):1-17. Review.

PMID:
11225502
13.

The epidemiology of generalized anxiety disorder.

Kessler RC, Keller MB, Wittchen HU.

Psychiatr Clin North Am. 2001 Mar;24(1):19-39. Review.

PMID:
11225507
14.

Comorbidity in generalized anxiety disorder.

Noyes R Jr.

Psychiatr Clin North Am. 2001 Mar;24(1):41-55. Review.

PMID:
11225508
15.

Duloxetine: a balanced and selective norepinephrine- and serotonin-reuptake inhibitor.

Westanmo AD, Gayken J, Haight R.

Am J Health Syst Pharm. 2005 Dec 1;62(23):2481-90. Review.

PMID:
16303903
16.

Duloxetine in the treatment of generalized anxiety disorder.

Kornstein SG, Russell JM, Spann ME, Crits-Christoph P, Ball SG.

Expert Rev Neurother. 2009 Feb;9(2):155-65. doi: 10.1586/14737175.9.2.155. Review.

PMID:
19210191
17.

Current considerations in the treatment of generalized anxiety disorder.

Katzman MA.

CNS Drugs. 2009;23(2):103-20. doi: 10.2165/00023210-200923020-00002. Review.

PMID:
19173371
18.
19.

[Alpha-interferon and mental disorders].

Debien C, De Chouly De Lenclave MB, Foutrein P, Bailly D.

Encephale. 2001 Jul-Aug;27(4):308-17. Review. French.

PMID:
11686052
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk